Stocks
AMRIZE LTD (US) CMNAMRS
HealthcareBiotechnology
A pharmaceutical company focused on the development and commercialization of therapies for orphan diseases and other unmet medical needs. Its pipeline and approved products target conditions with limited treatment options, making it a name watched by investors interested in specialty biotech. The company's financial performance and regulatory milestones are key drivers of its stock valuation.
Congressional Interest in AMRIZE LTD (US) CMN (AMRS)
1 member of Congress has disclosed 1 trade in AMRIZE LTD (US) CMN (AMRS), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading AMRS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-05-21 | Rohit Khanna | buy | $1K-$15K |